Illumina | ILMN - Interest Expense On Debt


Illumina reported $26M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Agilent USD 25M 0 Mar/2026
Bio Techne USD 2.17M 9K Dec/2025
Bio-Rad Laboratories USD 12.1M 200K Dec/2025
Boston Scientific USD 90M 0 Mar/2026
Bruker USD 8.1M 11.9M Dec/2025
Charles River Laboratories USD 26.74M 2.97M Mar/2026
Danaher USD 63M 8M Mar/2026
Dentsply International USD 24M 2M Mar/2026
Edwards Lifesciences USD 35.9M 2.7M Dec/2025
Illumina USD 26M 1000K Dec/2025
Intuitive Surgical USD 20.11B 58.39B Mar/2026
IQVIA Holdings USD 192M 1000K Mar/2026
Laboratory Of America USD 55.1M 100K Mar/2026
Mettler Toledo International USD 17.39M 307K Dec/2025
Myriad Genetics USD 4.4M 600K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Pacific Biosciences Of California USD 1.74M 1000 Dec/2025
Quest Diagnostics USD 69M 2M Sep/2025
Quidel USD 5.63B 5.58B Mar/2026
Repligen USD 5.58M 83K Mar/2026
Revvity USD 24.72M 1.2M Mar/2026
Roche Holding CHF 304M 7.5M Jun/2025
Standard Biotools USD 5K 5K Dec/2025
Thermo Fisher Scientific USD 354M 11M Mar/2026
Waters USD 42M 33.38M Mar/2026